PLAINSBORO, N.J., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has signed a new multi-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, to provide dural repair, neuro trauma (neuro critical care), neuro instrumentation, hydrocephalus and neurosurgical closure products to Premier's member hospitals.

"We are very pleased that Premier has selected Integra as a contracted provider of market-leading neurosurgical products to its broad base of over 2,500 acute healthcare facilities," said Chris Thatcher, President, Integra Neurosurgery. "The renewal of this contract validates our long standing relationship and commitment to provide Premier's client base with the most advanced and innovative neurosurgical products and highest quality services."

"Integra is one of the world's largest suppliers of neurosurgical products, and we're very excited that we've been able to renew our contract with Premier and offer its members access to our extensive product lines," said Tim McCarthy, Vice President of Sales. "Furthermore, we are the only vendor currently contracting with Premier for Neuro Critical Care products, such as our Camino® monitoring system, which helps limit uncertainty in the important area of monitoring patients in a hospital's neuro intensive care unit."

Premier's member hospitals will also have access to Integra's DuraGen^® family of products for dural repair, which are backed by an extensive safety record and have been used in over 1,000,000 implantations; and its devices for the management of hydrocephalus, which include the OSV II^® and Integra NPH™ systems, both of which offer a unique flow-regulating valve that constantly adjusts to meet a patient's changing physiological requirements without the need for external programming. Integra also offers one of the industry's most comprehensive surgical instruments inventory, through its Ruggles™-Redmond™ Neuro/Spine Instruments.

Integra is a leading provider of products used for dural repair, tissue ablation, management of hydrocephalus, neuromonitoring and drainage. Brands associated with Integra are DuraGen^® duraplasty products, CUSA^® systems, Camino^® and Licox^® systems, OSV II^® and Integra NPH valves, MAYFIELD^® devices, and Ruggles™-Redmond™Neuro/Spine Instruments.

About Integra LifeSciences

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com

About the Premier Healthcare Alliance, Malcolm Baldrige National Quality Award recipient

Premier is a performance improvement alliance of more than 2,500 U.S. hospitals and 75,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. http://www.premierinc.com. Stay connected with Premier on Facebook, Twitter and YouTube.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Integra products may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.

MAYFIELD is a registered trademark of SM USA, Inc. and is used by Integra under license.

CONTACT: Integra LifeSciences Holdings Corporation

         

         Gianna Sabella

         Director, Corporate Communications

         (609) 936-2389

         gianna.sabella@integralife.com